FDA Advises Sponsor-Investigators on Submitting INDs

Drug Industry Daily
The FDA has issued draft guidance spelling out in detail how to prepare and submit an IND if the sponsor is an investigator and not a commercial entity — saying sponsor-investigators often lack the regulatory know-how to submit a proper IND.

To View This Article:


Subscribe To Drug Industry Daily